CellSearch-based isolation of circulating tumor cells from ascitic fluid enables molecular characterization of ovarian cancer.
Cancer cells isolated from fluid samples perfectly matched tumor genes, supporting this gentle blood test as a way to track advanced ovarian cancer over time.
This PubMed record reports a observational or experimental journal study on CellSearch-based isolation of circulating tumor cells from ascitic fluid enables molecular characterization of ovarian cancer. The authors report that the complete mutational concordance between AF-derived CTCs and matched tumor tissue supports the biological validity of this approach and highlights its potential as a minimally invasive liquid biopsy for tumor characterization and longitudinal disease monitoring in advanced HGSOC.
What the study was
- Study design
- Observational or experimental journal study
- Population
- Human participants or clinical records described in the abstract
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- The journal of liquid biopsy
Why it surfaced
Observational or experimental journal study with direct human relevance was scored conservatively from PubMed abstract and citation metadata.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.